Cargando…
Chromosomal instability and a deregulated cell cycle are intrinsic features of high‐risk gastrointestinal stromal tumours with a metastatic potential
Patients with localised, high‐risk gastrointestinal stromal tumours (GIST) benefit from adjuvant imatinib treatment. Still, approximately 40% of patients relapse within 3 years after adjuvant therapy and the clinical and histopathological features currently used for risk classification cannot precis...
Autores principales: | Namløs, Heidi Maria, Khelik, Ksenia, Nakken, Sigve, Vodák, Daniel, Hovig, Eivind, Myklebost, Ola, Boye, Kjetil, Meza‐Zepeda, Leonardo A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620130/ https://www.ncbi.nlm.nih.gov/pubmed/37622176 http://dx.doi.org/10.1002/1878-0261.13514 |
Ejemplares similares
-
Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report
por: Namløs, Heidi M., et al.
Publicado: (2017) -
Personal Cancer Genome Reporter: variant interpretation report for precision oncology
por: Nakken, Sigve, et al.
Publicado: (2018) -
Sample-Index Misassignment Impacts Tumour Exome Sequencing
por: Vodák, Daniel, et al.
Publicado: (2018) -
Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines
por: Giliberto, Mariaserena, et al.
Publicado: (2022) -
Performance comparison of four exome capture systems for deep sequencing
por: Chilamakuri, Chandra Sekhar Reddy, et al.
Publicado: (2014)